University Hospital Zurich
Zurich, 8091, Switzerland
NCT Number: NCT04373109
COVID-19 has a big impact on individuals and society as a whole. Especially persons with (multiple) comorbidities such as stroke are affected. The impact of COVID-19 on stroke rehabilitation delivery and stroke patients' functioning is unclear.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Zurich, 8091, Switzerland
With 16'000 patients hospitalized and with new permanent disability in approximately 7'000 individuals every year in Switzerland, stroke has a major impact on quality of life and is an enormous socioeconomic burden. Virtually all patients receive inpatient rehabilitation in the sub-acute phase poststroke. However, also in the later phases poststroke, patients receive rehabilitation interventions in outpatient rehabilitation clinics and private practices, with goal to improve or maintain their functional capacity.
Currently, Switzerland finds itself in an extraordinary situation. The Federal Council has issued a series of measures aimed at the population, organizations and institutions, and the cantons. The aim is to curb the spread of the coronavirus and assure the provision of healthcare. The people are invoked to stay at home and only leave the home if absolutely necessary. If they are over the age of 65 or have an underlying medical condition, the Federal Council strongly recommend that you stay at home under any circumstances unless you have to go to the doctor.
With the recommendation of the Swiss Federal Council almost all stroke patients belong to the group who should stay home. Furthermore, all outpatient rehabilitation clinics have reduced the interventions to a minimum. It is unknown how a sudden stop of rehabilitation influences the stroke patients' functional capacities and their perceived quality of life.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation of intensity of rehabilitation therapy, daily life upper limb use, physical activi-ty engagement, patient-reported quality of life, and motor outcome after stroke
Time frame: 3 month after start lockdown
Nature of rehabilitation therapy, and number and duration of rehabilitation therapy sessions
Time frame: 3 month after start lockdown
Patient-reported upper limb use in daily life
Time frame: 3 month after start lockdown
Patient-reported engagement in physical activity in daily life
Time frame: 3 month after start lockdown
Patient-self-assessment comprising the following categories: 1) physical function, 2) anxiety, 3) depression, 4) fatigue, 5) sleep disturbance, 6) ability to participate in social roles and activities, 7) pain interference and 8) pain intensity
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Patient-reported global rating of physical activity engagement and upper limb use in daily life
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Self-reported questionnaire regarding severity of fatigue and its influence on the performance of daily life activities
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Depression and anxiety
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Assesses cognitive functions
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Classification regarding the ability to walk independently, with or without a walking aid and takes the type of walking surface into account
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Gait speed and cadence
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Measures the ability of patients to make postural adjustments (e.g, move in bed), transfer (e.g. be-tween bed to chair), walk, and use stairs
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Self-reported measure in which patients rate how confident they are in maintaining balance when performing 16 daily life tasks
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Upper and lower limb motor function
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Upper limb capacity
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Global disability
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Neurological impairments
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Nature of rehabilitation therapy, and number and duration of rehabilitation therapy sessions
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Patient-reported upper limb use in daily life
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Patient-reported engagement in physical activity in daily life
Time frame: 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Patient-self-assessment comprising the following categories: 1) physical function, 2) anxiety, 3) depression, 4) fatigue, 5) sleep disturbance, 6) ability to participate in social roles and activities, 7) pain interference and 8) pain intensity
Jeremia Held
Other
Acronym: SROCL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05258500
Atrophy, Brain Diseases
Jette, Brussels Capital, Belgium
View Trial DetailsNCT05226416
Anemia, Arrhythmias, Cardiac
Moscow, Russia
View Trial DetailsNCT04611425
Acute Respiratory Failure, Brain Diseases
Nantes, France
View Trial DetailsNCT07454655
Brain Diseases, Cardiovascular Diseases
Gaziantep, Turkey (Türkiye)
View Trial Details